Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Single-blind, Randomized, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Adding CARTISTEM® on Microfracture in Patients With Talar Chondral or Osteochondral Defect

NCT04310215 is registered in ClinicalTrials.gov with Hyundai Bioland Co., Ltd. as lead sponsor.

NCT NCT04310215
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04310215 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Single-blind, Randomized, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Adding CARTISTEM® on Microfracture in Patients With Talar Chondral or Osteochondral Defect
Lead sponsor
Hyundai Bioland Co., Ltd.
Phase
Phase 3
Overall status
Completed
Start date
March 3, 2020
Completion date
June 13, 2022
Enrollment
102 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

chondral or osteochondral lesion of talus